Sign In
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- US Share Prices
- Stock Tips
- Share Chat
- FX
- News & RNS
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Angle Share News (AGL)
AGL Share
Price
AGL Share
News
AGL Share
Chat
AGL Share
Trades37
AGL
Live RNS
AGL Share
Charts
AGL Broker
Ratings
AGL Directors
Deals
AGL Financial
Diary
AGL
Fundamentals
AGL Short
Positions
AGL
Media
AGL Company
Research
AGL Company
Timeline
- There is currently no data for AGL
IN BRIEF: Angle highlights supportive data for DNA analysis tool
Angle PLC - Surrey-based medical diagnostics provider - Announces publication of a peer-reviewed paper in a special issue of the journal - "Current Issues in Molecular Biology" Special Issue: Advanced Solutions for Cancer Therapy. Article brings together supporting evidence for the additional and complementary information that can be obtained from circulating tumour cells, demonstrating the value of a dual analyte approach for both CTCs and ctDNA (fragments of DNA released mainly by dying cells). Angle recently announced breakthrough data for real-time parallel next generation sequencing DNA analysis of both ctDNA and CTCs from a single tube of patient blood, using a pan-cancer panel run on an Illumina NGS system.
Current stock price: 17.85 pence, down 8.5% in London on Monday
12-month change: down 42%
By Jeremy Cutler, Alliance News reporter
Comments and questions to newsroom@alliancenews.com
Copyright 2024 Alliance News Ltd. All Rights Reserved.
Latest AGL News
- Angle shares up on assay development deal with AstraZenaca
3 May 2024 - AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal
3 May 2024 - LONDON MARKET OPEN: Confident start before US jobs data
3 May 2024 - Angle strikes supplier deal with AstraZeneca
3 May 2024 - LONDON BRIEFING: InterContinental Hotels makes first-quarter progress
3 May 2024 - CORRECT: No record close for FTSE 100; mixed trade in US
24 Apr 2024 - LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US
24 Apr 2024 - Angle shares jump on supplier agreement with with AstraZeneca
24 Apr 2024
Related News
IN BRIEF: Angle names Peter Collins as interim CEO
(Alliance News) - Angle PLC - Guildford, England-based liquid biopsy company, which is to be renamed CelLBxHealth PLC - Appoints Peter Collins as inte...
Angle touts planned name and strategy change, Groen turns executive
(Alliance News) - Angle PLC shares fell on Wednesday, after it announced plans to rename itself CelLBxHealth PLC and "[pursue] a revised strategy", wi...
IN BRIEF: Angle CEO and finance lead step down after shareholder talks
Angle PLC - Guildford, England-based liquid biopsy company - Says that, following talks with an unnamed "significant shareholder", Chief Executive Off...
Angle News
Angle shares up on assay development deal with AstraZenaca
(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsort...
AIM WINNERS & LOSERS: Fletcher King optimistic; Angle in Astra deal
(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Friday.
LONDON MARKET OPEN: Confident start before US jobs data
(Alliance News) - Stock prices in London opened higher on Friday, on the rising conviction that the afternoon's US jobs report will be softer, cooling...
Angle strikes supplier deal with AstraZeneca
(Sharecast News) - Liquid biopsy technology firm Angle has struck a supplier deal with pharmaceutical giant AstraZeneca to develop an androgen recepto...
LONDON BRIEFING: InterContinental Hotels makes first-quarter progress
(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out...
CORRECT: No record close for FTSE 100; mixed trade in US
(Correcting day of the week in the opening sentence.)
LONDON MARKET CLOSE: No record close for FTSE 100; mixed trade in US
(Alliance News) - Stock prices in London closed lower on Thursday, with the FTSE 100's recent rally taking a pause for breath, but not after hitting a...
Angle shares jump on supplier agreement with with AstraZeneca
(Alliance News) - Angle PLC shares rose on Wednesday, after it signed a contract with AstraZeneca PLC.
Follow the stocks
